-The Business Standard A ray of hope for Indian generic drug makers Gilead Sciences, the California-headquartered biotechnology company, has authorised seven India-based drug makers - Cipla, Ranbaxy, Mylan, Strides Arcolab, Hetero, Cadila Healthcare and Sequent Scientific - to manufacture and sell the generic versions of its hepatitis C medicine, Sovaldi, in 91 developing countries. Earlier in the week, Lupin, the fourth largest Indian drug maker, announced that it will develop and supply...

-The Times of India MUMBAI: Enterprising lawyers and gender equality experts have spotted a business opportunity in the new law against sexual harassment of women at work. With the Sexual Harassment of Women at Workplace (Prevention, Prohibition & Redressal) Act, 2013 raising major concerns with respect to corporate liability and a potential threat to reputation on non-compliance, organizations are turning to the pros. This new breed of consultants helps companies with gender...

-Down to Earth Vasundhara Raje government adopts targeted approach for the scheme which can now be availed only by beneficiaries of food security programme The Rajasthan government has downsized its much-acclaimed free medicines and diagnostics scheme, the Mukhyamantri Nishulk Dava Yojna, launched in 2011. The Vasundhara Raje-led BJP government has adopted a "targeted approach" in implementing the scheme which was a "universal" one when launched by the previous Congress-led UPA regime. Public...

-The Hindu   Obesity among children due to rampant consumption of junk food has reached epidemic proportions. With India already in the grip of this dangerous global trend, the government needs to remove its blinkers on the processed food industry One of the first declarations of the newly elected government in June was a proposal to ban unhealthy or junk food (defined as food high on fat, sugar and salt) in school...

-The Business Standard   Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical Companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market,...